搜索临床试验以:伏诺拉赞 20 毫克 bid
总计1173个结果
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of Munich主动,不招人
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AG主动,不招人
-
Alexion Pharmaceuticals终止
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.主动,不招人
-
Merck Sharp & Dohme LLC终止DLBCL | AML,包括新发 AML 和继发于 MDS 的 AML
-
LG Life Sciences完全的
-
Jadran Galenski laboratorij d.d.完全的
-
Shaheed Zulfiqar Ali Bhutto Medical University完全的
-
Medicines for Malaria VentureNucleus Network Ltd; Southern Star Research Pty Ltd.完全的
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, Slovenia完全的
-
The HIV Netherlands Australia Thailand Research...Radboud University Medical Center; Bhumibol Adulyadej Hospital; Klang Hospital; Bamrasnaradura Infectious... 和其他合作者招聘中
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)完全的